Article · Volume 2, Issue 4 · pp. 311–312
ACE inhibitor and angiotensin-receptor blocker – A deadly combination
G. Sivagnanam1
Abstract
It is particular to note that ACE inhibitor/ARB combination therapy has been shown to offer no signifi cant clinical benefi ts over monotherapy, instead was associated with a worse safety and tolerability profi le. No morbidity and mortality data for direct renin inhibitor (DRI)/ACEI or DRI/ARB combinations are currently available
Keywords: News and Views
The full text of this article is available as a PDF. Open the PDF.